北美给药系统市场至 2027 年 - 按给药途径(经粘膜、口服、注射、局部、植入和眼部)进行区域分析和预测;分销渠道(医院药房、零售药房、网上药房);和申请(家庭护理机构、医院和诊所等)以及国家/地区

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 249    |    Report Code: TIPRE00005752    |    Category: Life Sciences

North America Drug Delivery Systems Market

北美人体给药系统市场预计将从 2018 年的 572,453.0 百万美元增至 2027 年的 1,074,679.7 百万美元。预计该市场将以 7.4% 的复合年增长率增长2019-2027年。

 

推动市场增长的关键因素是对大众用药、各市场参与者为维持其市场领导地位而开展的广泛研究和开发项目,从而推出新的创新产品以及在该地区建立完善的制药和医疗器械行业。

 

在过去的几十年里,由于慢性病的患病率不断增加,药物输送装置的研发 (R&D) 在全球范围内不断增加。疾病。药物递送是施用药物化合物以在人体中达到治疗效果的方法或过程。为了治疗这些慢性疾病,正在研究各种给药途径。根据美国疾病控制与预防中心 (CDC) 2019 年的数据,美国近十分之六的人患有至少一种慢性病,十分之四的人患有两种或两种以上慢性病。此外,癌症是北美地区的主要原因之一。此外,美国癌症协会 (ACS) 估计,2018 年大约诊断出 1,735,350 例新癌症病例。靶向药物递送系统(TDDS)是一种以受控方式在预先选定的生物位点递送药物的系统。糖尿病是一种危及生命的慢性疾病,没有专门的治疗方法。所有类型的糖尿病都会导致身体许多部位出现各种并发症,并会增加过早死亡的总体风险。例如,根据国际糖尿病联盟(IDF)的数据,2017年北美糖尿病患者数量约为4600万,预计到2045年将达到6200万。因此,患有一种糖尿病的患者数量不断增加或更多的慢性疾病预计将在未来几年推动药物输送设备市场的增长。

 

美国药物输送系统市场预计在预测期内将以最高速度增长。该市场的增长主要是由于糖尿病、哮喘等慢性疾病的患病率不断上升,主要参与者推出的产品数量不断增加;以及更多地使用药物输送系统进行疾病管理。美国地区给药系统市场预计将从2018年的3883.5924亿美元增至2027年的7415.2896亿美元。预测期内该地区市场增长率预计为7.6%。

2027 年北美给药系统市场收入及预测(百万美元)


北美药物输送系统–市场细分

按给药途径

  • 口服< /span>
    • 固体口服药物
    • 液体口服药物
    • 半固体口服药物药物
  • 经粘膜
    • 肺部药物输送
      • 计量吸入器
      • 干粉吸入器
      • 雾化器
      • 鼻腔给药
        • 鼻喷雾剂
        • 滴鼻剂
        • 鼻用凝胶
      • 口腔给药
      • 舌下给药
      • 直肠跨粘膜给药
      • 阴道跨粘膜给药
      • 可注射
        • 传统注射装置
        • 自注射装置
          • 无针注射器
          • 笔式注射器
          • 可穿戴式注射器< /li>
      • 外用
        • 半固体外用给药制剂
        • 液体外用药物输送制剂
        • 固体外用药物输送制剂
        • 透皮贴剂
        • 透皮凝胶
        • 其他
      • 植入式
        • 主动植入式
        • 被动植入式
      • 眼科
        • 眼药水和眼药水喷雾剂
        • 凝胶和凝胶剂软膏
        • 眼科植入物
      • 药物涂层隐形眼镜

      北美药物输送系统 –市场细分

      按应用

      • 医院和医疗机构诊所
      • 家庭护理机构
      • 其他

      北美药物输送系统 –市场细分

      分销渠道

      • 医院药房
      • 零售药房
      • 网上药房

         

      按国家/地区

      • 美国
      • 加拿大
      • 墨西哥

      提及的公司

      < /span>

      • BD
      • 诺和诺德公司
      • 3M
      • 波士顿科学公司
      • 博士健康公司
      • 百特国际公司
      • 勃林格殷格翰
      • 诺华公司
      • < span>葛兰素史克公司。
      • 强生公司约翰逊服务公司


      North America Drug Delivery Systems Strategic Insights

      Strategic insights for North America Drug Delivery Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

      strategic-framework/north-america-drug-delivery-systems-market-strategic-framework.webp
      Get more information on this report

      North America Drug Delivery Systems Report Scope

      Report Attribute Details
      Market size in 2018 US$ 572,453.0 Million
      Market Size by 2027 US$ 1,074,679.7 Million
      Global CAGR (2019 - 2027) 7.4%
      Historical Data 2016-2017
      Forecast period 2019-2027
      Segments Covered By 给药途径
      • 透粘膜
      • 口服
      • 注射
      • 外用
      • 植入
      • 眼部
      By 分销渠道
      • 医院药房
      • 零售药房
      • 网上药房
      By 应用
      • 家庭护理环境
      • 医院和诊所
      Regions and Countries Covered 北美
      • 美国
      • 加拿大
      • 墨西哥
      Market leaders and key company profiles
    • BD
    • Novo Nordisk A/S
    • 3M
    • Boston Scientific Corporation
    • Bausch Health Companies Inc.
    • Baxter International, Inc.
    • Boehringer Ingelheim
    • Novartis AG
    • GlaxoSmithKline plc.
    • Johnson & Johnson Services, Inc.
    • Get more information on this report

      North America Drug Delivery Systems Regional Insights

      The regional scope of North America Drug Delivery Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

      geography/north-america-drug-delivery-systems-market-geography.webp
      Get more information on this report

The List of Companies - North America Drug Delivery Systems Market

The List of Companies - North America Drug Delivery Systems Market

1. BD
2. Novo Nordisk A/S
3. 3M
4. Boston Scientific Corporation
5. Bausch Health Companies Inc.
6. Baxter International, Inc.
7. Boehringer Ingelheim
8. Novartis AG
9. GlaxoSmithKline plc.
10. Johnson & Johnson Services, Inc.
Frequently Asked Questions
How big is the North America Drug Delivery Systems Market?

The North America Drug Delivery Systems Market is valued at US$ 572,453.0 Million in 2018, it is projected to reach US$ 1,074,679.7 Million by 2027.

What is the CAGR for North America Drug Delivery Systems Market by (2019 - 2027)?

As per our report North America Drug Delivery Systems Market, the market size is valued at US$ 572,453.0 Million in 2018, projecting it to reach US$ 1,074,679.7 Million by 2027. This translates to a CAGR of approximately 7.4% during the forecast period.

What segments are covered in this report?

The North America Drug Delivery Systems Market report typically cover these key segments-

  • 给药途径 (透粘膜, 口服, 注射, 外用, 植入, 眼部)
  • 分销渠道 (医院药房, 零售药房, 网上药房)
  • 应用 (家庭护理环境, 医院和诊所)
  • What is the historic period, base year, and forecast period taken for North America Drug Delivery Systems Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Drug Delivery Systems Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in North America Drug Delivery Systems Market?

    The North America Drug Delivery Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • BD
  • Novo Nordisk A/S
  • 3M
  • Boston Scientific Corporation
  • Bausch Health Companies Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim
  • Novartis AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Who should buy this report?

    The North America Drug Delivery Systems Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Drug Delivery Systems Market value chain can benefit from the information contained in a comprehensive market report.